Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 511 AL 525

Effects of 2 Years of Exercise on Gait Impairment in People With Parkinson Disease: The PRET-PD Randomized Trial

Rafferty MR, Prodoehl J, Robichaud JA, David FJ, Poon C, Goelz LC, Vaillancourt DE, Kohrt WM, Comella CL, Corcos DM.

J Neurol Phys Ther. 2017 Jan;41(1):21-30. doi: 10.1097/NPT.0000000000000163.

Exploring the Effects of Using an Oral Appliance to Reduce Movement Dysfunction in an Individual With Parkinson Disease: A Single-Subject Design Study

Lane H, Rose LE, Woodbrey M, Arghavani D, Lawrence M, Cavanaugh JT.

J Neurol Phys Ther. 2017 Jan;41(1):52-58. doi: 10.1097/NPT.0000000000000160.

Multiple Sclerosis and Neuroinflammation: The Overview of Current and Prospective Therapies

Bjelobaba I, Savic D, Lavrnja I.

Curr Pharm Des. 2017;23(5):693-730. doi: 10.2174/1381612822666161214153108.

The Effects of Meditation on Grey Matter Atrophy and Neurodegeneration: A Systematic Review

Last N, Tufts E, Auger LE.

J Alzheimers Dis. 2017;56(1):275-286. doi: 10.3233/JAD-160899.

Impulse control disorder, lysosomal malfunction and ATP13A2 insufficiency in Parkinsonism

Liu JP, Li J, Lu Y, Wang L, Chen G.

Clin Exp Pharmacol Physiol. 2017 Feb;44(2):172-179. doi: 10.1111/1440-1681.12714.

[Retinal imaging of the macula and optic disc in neurodegenerative diseases]

Turski GN, Schmitz-Valckenberg S, Holz FG, Finger RP.

Ophthalmologe. 2017 Feb;114(2):114-119. doi: 10.1007/s00347-016-0412-8.

Physical therapy and occupational therapy in Parkinson's disease

Radder DLM, Sturkenboom IH, van Nimwegen M, Keus SH, Bloem BR, de Vries NM.

Int J Neurosci. 2017 Oct;127(10):930-943. doi: 10.1080/00207454.2016.1275617. Epub 2017 Jan 4.

Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole

Selfani K, Soland VL, Chouinard S, Huot P.

Neurologist. 2017 Jan;22(1):24-28. doi: 10.1097/NRL.0000000000000096.

Genome-wide association study of Parkinson's disease in East Asians

Foo JN, Tan LC, Irwan ID, Au WL, Low HQ, Prakash KM, Ahmad-Annuar A, Bei J, Chan AY, Chen CM, Chen YC, Chung SJ, Deng H, Lim SY, Mok V, Pang H, Pei Z, Peng R, Shang HF, Song K, Tan AH, Wu YR, Aung T, Cheng CY, Chew FT, Chew SH, Chong SA, Ebstein RP, Lee J, Saw SM, Seow A, Subramaniam M, Tai ES, Vithana EN, Wong TY, Heng KK, Meah WY, Khor CC, Liu H, Zhang F, Liu J, Tan EK.

Hum Mol Genet. 2017 Jan 1;26(1):226-232. doi: 10.1093/hmg/ddw379.

The Pharmacology of Autonomic Failure: From Hypotension to Hypertension

Biaggioni I.

Pharmacol Rev. 2017 Jan;69(1):53-62. doi: 10.1124/pr.115.012161.

Serotonin transporter in Parkinson's disease: A meta-analysis of positron emission tomography studies

Pagano G, Niccolini F, Fusar-Poli P, Politis M.

Ann Neurol. 2017 Feb;81(2):171-180. doi: 10.1002/ana.24859.

A Mini Review on the Chemistry and Neuroprotective Effects of Silymarin

Devi KP, Malar DS, Braidy N, Nabavi SM, Nabavi SF.

Curr Drug Targets. 2017;18(13):1529-1536. doi: 10.2174/1389450117666161227125121.

Nano-medicine Improving the Bioavailability of Small Molecules for the Prevention of Neurodegenerative Diseases

Di Martino P, Censi R, Gigliobianco MR, Zerrillo L, Magnoni F, Agas D, Quaglia W, Lupidi G.

Curr Pharm Des. 2017;23(13):1897-1908. doi: 10.2174/1381612822666161227154447.

Opicapone as Adjunct to Levodopa Therapy in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial

Lees AJ, Ferreira J, Rascol O, Poewe W, Rocha JF, McCrory M, Soares-da-Silva P; BIPARK-2 Study Investigators.

JAMA Neurol. 2017 Feb 1;74(2):197-206. doi: 10.1001/jamaneurol.2016.4703.

Recommendations for the Treatment of Patients With Parkinson Disease During Ramadan

Damier P, Al-Hashel J.

JAMA Neurol. 2017 Feb 1;74(2):233-237. doi: 10.1001/jamaneurol.2016.4291.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias